QA: Opiant Pharmaceuticals INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001385508_2018_Opiant_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001385508, Opiant Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 10,787,442
1 IntangibleAssetsNetIncludingGoodwill 17,690
2 PropertyPlantAndEquipmentNet 2,753
3 remainder_Assets 0
4 LiabilitiesCurrent 4,166,949
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,306,527
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,194,025
9 ResearchAndDevelopmentExpense 2,707,024
10 remainder_Expenses 2,162,961
11 remainder_Revenues 61,113,780
12 remainder_NetIncome 52,563
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 10,807,885
1 Liabilities 6,473,476
2 Expenses 15,064,010
3 Revenues 61,113,780
4 StockholdersEquity 4,334,409
5 NetIncome 46,102,333
6 ComprehensiveNetIncome 46,102,333
7 BaseVar 46,755,857
8 EconomicCapitalRatiobeforeLimitedLiability 6.43
9 EconomicCapitalRatio 6.48

Edgar->Model Mapping

Feature Distribution

Change over Time